MAPT and Alzheimer disease: In an earlier study, Andersson et al. showed that KLC1 SNPs, including rs8702, may influence AD pathogenesis, especially in conjunction with APOE ε4, by affecting hyperphosphorylated tau levels in cerebrospinal fluid (Andersson et al., 2007).